Drug company Actavis recently made a bid for Allergan, but the Botox maker rejected the proposal and is closing in on its own takeover for Salix Pharmaceuticals.
WSJ.com: What's News US, Wall Street Journal
Mon, 09/22/2014 - 5:13pm
Drug company Actavis recently made a bid for Allergan, but the Botox maker rejected the proposal and is closing in on its own takeover for Salix Pharmaceuticals.